| Ecolab Inc. (NYSE: ECL): |
| Fourth Quarter Highlights |
- Reported sales of $4.0 billion, +2% versus last year.
|
- Organic sales +4%, with accelerated growth in the Industrial and Healthcare & Life Sciences segments and continued strong growth in the Pest Elimination and Institutional & Specialty segments. Regionally, organic sales growth remained very strong in the United States, and growth across the rest of the world was good as new business wins more than offset uneven macroeconomic trends.
|
- Reported operating income margin 14.6%. Organic operating income margin 17.4%, +150 bps as solid sales growth more than offset growth-oriented investments in the business.
|
- Reported diluted EPS $1.66, +18%. Adjusted diluted EPS, excluding special gains and charges and discrete tax items, were $1.81, +17%.
|
- Full-year 2024 cash flow from operating activities $2.8 billion. Record full-year 2024 free cash flow of $1.8 billion.
|
| Outlook |
- 2025: Expect the full year 2025 adjusted diluted earnings per share in the $7.42 to $7.62 range, +12% to 15% versus last year, including an approximate 4% unfavourable impact on earnings growth from currency translation.
|
- 1Q 2025: Expect first quarter 2025 adjusted diluted earnings per share in the $1.47 to $1.53 range, +10% to 14%, including an approximate 4% unfavourable impact on earnings growth from currency translation.
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Fourth Quarter Ended December 31 |
| |
|
Reported |
|
|
|
|
Adjusted |
|
|
|
|
| (unaudited) |
|
Public Currency Rates |
|
% |
|
Public Currency Rates |
|
% |
| (millions, except per share) |
|
2024 |
|
2023 |
|
Change |
|
2024 |
|
|
2023 |
|
Change |
|
| Net sales |
|
$4,005.2 |
|
|
$3,938.4 |
|
|
2 |
% |
|
$4,005.2 |
|
|
$3,938.4 |
|
|
2 |
% |
|
| Operating income |
|
582.8 |
|
|
590.0 |
|
|
(1) |
% |
|
688.2 |
|
|
624.5 |
|
|
10 |
% |
|
| Net income attributable to Ecolab |
|
472.9 |
|
|
405.2 |
|
|
17 |
% |
|
516.6 |
|
|
444.7 |
|
|
16 |
% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted earnings per share attributable to Ecolab |
|
$1.66 |
|
|
$1.41 |
|
|
18 |
% |
|
$1.81 |
|
|
$1.55 |
|
|
17 |
% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Organic |
|
% |
|
|
|
|
|
|
|
|
|
|
| |
|
2024 |
|
2023 |
|
Change |
|
|
|
|
|
|
|
|
|
|
| Net sales |
|
$4,021.5 |
|
|
$3,861.8 |
|
|
4 |
% |
|
|
|
|
|
|
|
|
|
|
| Operating income |
|
698.6 |
|
|
612.4 |
|
|
14 |
% |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CEO Comment |
| Christophe Beck, Ecolab’s chairman and chief executive officer, said, “2024 was another exceptional year for Ecolab, with sales, organic operating income margin, free cash flow, and adjusted diluted earnings per share all reaching record levels. This outstanding performance was fueled by the significant total value the Ecolab team and technologies delivered to our customers. We also continued to invest in breakthrough innovation, new digital capabilities, and our sales and service expertise. These efforts aim to further strengthen Ecolab’s competitive position, enhance our customer value proposition, and create new growth opportunities for the future. |
| “We enter 2025 confident in our ability to deliver continued strong performance in a dynamic environment. Growth in the United States, our largest and most profitable region, continues to be very strong, and growth across the rest of the world is solid as we more than offset uneven macroeconomic trends. We expect to continue this good momentum by generating further market share gains through our One Ecolab initiative and accelerating performance in our growth engines, specifically in datacentress, microelectronics, life sciences, and Ecolab digital. Additionally, we will implement value pricing that reflects the increasing value Ecolab delivers to customers. As a result, we expect to deliver attractive organic operating income margin expansion as our confidence in reaching our 20% margin target over the next three years continues to strengthen. Ecolab’s business fundamentals, momentum, and balance sheet are strong, and we remain incredibly focused on generating superior shareholder returns in 2025 and beyond.” |
| Fourth Quarter 2024 Consolidated Results |
| Ecolab’s fourth quarter reported sales increased 2%, and organic sales increased 4% when compared to the prior year. |
| The fourth quarter of 2024 reported operating income decreased by 1%, including the impact of special gains and charges, which were a net charge primarily related to restructuring costs. Organic operating income increased 14%, as solid sales growth more than offset growth-oriented investments in the business. |
| Reported other income in the fourth quarter of 2024 decreased by $5 million due to higher pension costs. Reported net interest expense decreased $9 million, reflecting lower interest expense due to lower interest rates. |
| The reported income tax rate for the fourth quarter of 2024 was 10.3% compared with the reported rate of 23.6% in the fourth quarter of 2023. Excluding special gains and charges and discrete tax items, the adjusted tax rate for the fourth quarter of 2024 was 18.2% compared with the adjusted tax rate of 21.3% in the fourth quarter of 2023. The lower adjusted tax rate reflected changes in the geographic mix of income and tax planning. |
| Reported net income increased 17% versus the prior year. Excluding the impact of special gains and charges and discrete tax items, adjusted net income increased 16% versus the prior year. |
| Reported diluted earnings per share increased 18% versus the prior year. Adjusted diluted earnings per share increased by 17% when compared to the fourth quarter of 2023. |
| Currency translation had a $0.01 unfavourable impact on earnings per share in the fourth quarter of 2024. |
| Business Outlook |
| 2025 |
| Secular growth trends in water, hygiene, and infection prevention continue to fuel resilient demand for Ecolab’s innovative technologies and services. Regionally, Ecolab expects macroeconomic trends in the United States, the company’s largest and most profitable region, to strengthen further and trends across the rest of the world to remain uneven. |
| Momentum in new growth verticals across digital, data centres, microelectronics, and life sciences is expected to continue to accelerate. Ecolab’s investments in these areas position the company well to capture these attractive growth opportunities. |
| Externally, currency translation is expected to have an approximate 3% unfavourable impact on Ecolab’s 2025 reported sales growth and a 4% unfavourable impact on adjusted diluted earnings per share growth. The company expects to mitigate the impact on earnings through stronger value pricing, which is expected to be slightly higher than 2024’s pricing as Ecolab’s total value delivered to customers continues to expand and through One Ecolab, savings coming in slightly faster than expected. |
| As a result, Ecolab expects full-year2025 adjusted diluted earnings per share to improve further to the $7.42 to $7.62 range, rising 12% to 15% compared with adjusted diluted earnings per share of $6.65 in 2024. |
| The company currently expects quantifiable special charges in 2025 to be approximately $0.25 to $0.30 per share, principally related to restructuring charges. Other than the special gains and charges noted above, other such amounts are not currently quantifiable. |
| 2025 – First Quarter |
| Ecolab expects first quarter 2025 adjusted diluted earnings per share in the $1.47 to $1.53 range, rising 10% to 14% compared with adjusted diluted earnings per share of $1.34 a year ago. This range includes an estimated 4% unfavourable impact on adjusted diluted earnings per share growth from currency translation. |
| The company currently expects quantifiable special charges in the first quarter of 2025 to be $0.12 per share, principally related to restructuring charges. Other than the special gains and charges noted above, other such amounts are not currently quantifiable. |
| New 2025 Segment Alignment |
| Effective in the first quarter of 2025, Ecolab will modify its segment reporting. Ecolab’s Global Industrial segment will be renamed Global Water and include Light & Heavy (previously named Water), Food & Beverage, and Paper. Ecolab’s Global Institutional & Specialty segment will continue to include Institutional and Specialty. The company’s healthcare business will move into Institutional. Global Life Sciences will be elevated to a standalone segment. The Global Pest Elimination segment will remain a standalone segment. Further details, including 2023 and 2024 sales and operating income shown in the new segment format and translated at 2025 fixed currency exchange rates, are expected to be disclosed in Form 8-K before Ecolab reports its first quarter 2025 results. |
| About Ecolab |
| A trusted partner for millions of customers, Ecolab (NYSE: ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high-tech, life sciences, hospitality and industrial markets. www.ecolab.com |
| Ecolab will host a live webcast to review the fourth quarter earnings announcement today at 1:00 p.m. Eastern Time. The webcast, along with related materials, will be available to the public on Ecolab's website at www.ecolab.com/investor. A replay of the webcast and related materials will be available on that site. |
| For the full document, click the link below: |
| Ecolab Inc |
| Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies. |
